Journals / Annals of Medical Research / 2022 / Cilt: 29 - Sayı: 4

Is the MTHFR C677T variant a genetic risk factor in the etiology of autism spectrum disorder? Is it alone or by combined with rare variants of the PHGDH gene?

Pages
334–340
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: No data were found to support that the MTHFR C677T variant alone or in combination with rare variants of the PHGDH gene is a genetic risk factor in the etiology of ASD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Autism spectrum disorder (ASD) is a group of diseases characterized by restricted interests, speech disorders, lack of reciprocal social communication.
📊
Key Findings & Data:The C677T in the methylenetetrahydrofolate reductase (MTHFR) gene has been associated with the increased genetic liability for ASD in many studies.
💡
Conclusion & Impact:Conclusion: No data were found to support that the MTHFR C677T variant alone or in combination with rare variants of the PHGDH gene is a genetic risk factor in the etiology of ASD.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Autism spectrum disorder (ASD) is a group of diseases characterized by restricted interests, speech disorders, lack of reciprocal social communication. Genetic factors are predominantly responsible for the etiology of ASD. ASD genetics is complex and heterogeneous, and a variety of genetic factors has been associated with ASD. The C677T in the methylenetetrahydrofolate reductase (MTHFR) gene has been associated with the increased genetic liability for ASD in many studies. In the present study, we asked whether the MTHFR C677T variant increases the risk of ASD alone or in combination with rare harmful SNVs (MAF values are ≤ 0.001) on the phosphoglycerate dehydrogenase gene (PHGDH) in the genetic etiology of ASD. Materials and Methods: Two hundred twenty-two patients with ASD and 323 neurotypical controls were included in this study. PCR and Restriction Fragment Length Polymorphism method was used for screening the C677T. The PHGDH gene was scanned in the groups by targeted next-generation sequencing carrying C677T variant as homo-or heterozygous. Allele and genotype distributions of the C677T were analyzed by using the chi-square test. Genotype distributions were analyzed according to all four possible genetic models; homozygote (TT vs CC), heterozygote (CT vs CC), dominant (TT+CT vs CC), and recessive (TT vs CT+CC). Results: There was not any significant difference in terms of C and T allele distributions between ASD and controls (T vs C: OR = 1.16, 95% CI = 0.89-1.5, p > 0.05). There were not any significant different distributions of the 4 possible genotypes. In possible combined effects of the C677T and rare and possibly harmful SNVs of the PHGDH in the genetic etiology of ASD, we could not find any differences between patients and controls. Conclusion: No data were found to support that the MTHFR C677T variant alone or in combination with rare variants of the PHGDH gene is a genetic risk factor in the etiology of ASD.

🔖

Cite This Article

KASAP, B. K., BİLGİNER, Ç., YILDIZ, G., TORAMAN, B. (2022). Is the MTHFR C677T variant a genetic risk factor in the etiology of autism spectrum disorder? Is it alone or by combined with rare variants of the PHGDH gene?. Annals of Medical Research, Cilt: 29 - Sayı: 4, 334–340. https://ajindex.com/articles/445599

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. American Psychiatric Association. Cautionary Statement for Forensic Use of DSM-5. In: Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. American Psychiatric Publishing, Inc; 2014
  2. Correction and Republication: Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1279
  3. Emberti Gialloreti L, Mazzone L, Benvenuto A, Fasano A, Alcon AG, Kraneveld A, et al. Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: EvidenceBased Principles and Recommendations. J Clin Med. 2019 Feb 8;8(2):217
  4. Tick B, Bolton P, Happé F, Rutter M, Rijsdijk F. Heritability of autism spectrum disorders: a meta-analysis of twin studies. J Child Psychol Psychiatry. 2016 May;57(5):585–95
  5. Chaste P, Roeder K, Devlin B. The Yin and Yang of Autism Genetics: How Rare De Novo and Common Variations Affect Liability. Annu Rev Genomics Hum Genet. 2017 Aug 31;18(1):167–87
  6. Wiśniowiecka-Kowalnik B, Nowakowska BA. Genetics and epigenetics of autism spectrum disorder—current evidence in the field. J Appl Genet. 2019 Feb 10;60(1):37–47
  7. Chang Y, Lin C, Huang H, Chang J, Kuo H. Chromosomal microarray and whole-exome sequence analysis in Taiwanese patients with autism spectrum disorder. Mol Genet Genomic Med. 2019 Dec 8;7(12):e996
  8. Krumm N, O’Roak BJ, Shendure J, Eichler EE. A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci. 2014 Feb;37(2):95–105
  9. Grove J, Ripke S, Als TD, Mattheisen M, Walters RK, Won H, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019 Mar 25;51(3):431–44
  10. Gaugler T, Klei L, Sanders SJ, Bodea CA, Goldberg AP, Lee AB, et al. Most genetic risk for autism resides with common variation. Nat Genet. 2014 Aug 20;46(8):881–5
  11. Klei L, Sanders SJ, Murtha MT, Hus V, Lowe JK, Willsey AJ, et al. Common genetic variants, acting additively, are a major source of risk for autism. Mol Autism. 2012 Dec 15;3(1):9
  12. Mato JM, Martínez-Chantar ML, Noureddin M, Lu SC. OneCarbon Metabolism in Liver Health and Disease. In: Liver Pathophysiology. Elsevier; 2017. p. 761–5
  13. Guo T, Chen H, Liu B, Ji W, Yang C. Methylenetetrahydrofolate reductase polymorphisms C677T and risk of autism in the Chinese han population. Genet Test Mol Biomarkers. 2012 Aug 1;16(8):968–73. 14